• Featured Product
  • KD/KO Validated

RNF26 Polyclonal antibody

RNF26 Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, IF, IP, CoIP, ELISA

Conjugate

Unconjugated

Cat no : 16802-1-AP

Synonyms

ring finger protein 26, RNF26


☆対象製品が30%オフ!組換えタンパク質&免染用試薬 >>> キャンペーン実施中!


Tested Applications

Positive WB detected inHepG2 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:200-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

The immunogen of 16802-1-AP is RNF26 Fusion Protein expressed in E. coli.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen RNF26 fusion protein Ag10285 相同性解析による交差性が予測される生物種
Full Name ring finger protein 26
Calculated molecular weight 433 aa, 48 kDa
Observed molecular weight 48 kDa
GenBank accession numberBC000058
Gene symbol RNF26
Gene ID (NCBI) 79102
RRIDAB_2878317
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Protocols

Product Specific Protocols
WB protocol for RNF26 antibody 16802-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB,IP

Int J Biol Sci

The RNF26/CBX7 axis modulates the TNF pathway to promote cell proliferation and regulate sensitivity to TKIs in ccRCC.

Authors - Wentao Liu
  • KD Validated
humanWB,CoIP,IHC

Cell Death Dis

The FOXM1/RNF26/p57 axis regulates the cell cycle to promote the aggressiveness of bladder cancer.

Authors - Lu Yi
  • KD Validated
humanWB,IP,IHC,IF

Br J Cancer

CDK4/6 inhibitors dephosphorylate RNF26 to stabilize TSC1 and increase the sensitivity of ccRCC to mTOR inhibitors

Authors - Xinlin Liu
  • KD Validated